Optimism Bias in the Design of Phase III Randomized Control Trials Evaluating PD-1/PD-L1 Targeting Monoclonal Antibodies

por Al-Showbaki, Laith, Almugbel, Fahad A, Alqaisi, Husam A, Amir, Eitan, Chen, Eric X
Publicado 2022

Network Meta-analysis Comparing Efficacy, Safety and Tolerability of Anti-PD-1/PD-L1 Antibodies in Solid Cancers

por Al-Showbaki, Laith, Nadler, Michelle B., Desnoyers, Alexandra, Almugbel, Fahad A., Cescon, David W., Amir, Eitan
Publicado 2021

Assessing frequency and clinical outcomes of BRCA mutated ovarian cancer in Saudi women

por Agha, Naela, Alshamsan, Bader, Al-Farsi, Sharifa, Ateya, Heba Aly, Almugbel, Fahad A., Alotaibi, Hazem Abdullah, Omar, Ayman, Mohamed, Amgad Shahin, Alharthy, Hanan, Elhassan, Tusneem, Salem, Hany, Alhusaini, Hamed
Publicado 2022